{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:03:25Z","timestamp":1792206205138,"version":"4.4.0"},"reference-count":63,"publisher":"Korean Pediatric Society","issue":"2","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Dipro Medical Research Fund","award":["DiCROH2304400330"],"award-info":[{"award-number":["DiCROH2304400330"]}]}],"content-domain":{"domain":["e-cep.org"],"crossmark-restriction":true},"short-container-title":["Clin Exp Pediatr"],"published-print":{"date-parts":[[2026,2,15]]},"abstract":"<jats:p>Background: Respiratory, gastrointestinal, and allergic diseases can significantly affect children\u2019s physical and mental health and quality of life.Purpose: This study aimed to assess the safety of Bifidobacterium animalis subsp. lactis BLa80, its preventive effects on morbidities related to respiratory, gastrointestinal, and allergic diseases, and its impact on the gut microbiome of children during the study period.Methods: Healthy children aged 0\u20133 years were randomly assigned to an intervention group (IG; n=180) or control group (CG; n=180). Participants received probiotics or placebo for 3 months, followed by a 3-month follow-up period. Children in the IG received one oral probiotic sachet daily for 90 consecutive days starting on the first day of the intervention. Each sachet contained maltodextrin and the BLa80 strain at 5\u00d7109 colony-forming units (CFUs). Children in the CG received placebo sachets containing maltodextrin only. The primary outcome measure was eczema morbidity during the 6-month study period. Secondary outcomes included acute upper respiratory tract infections (URTIs) and acute tracheitis\/bronchitis. Fecal gut microbiota profiles were assessed by 16S rRNA sequencing. Fecal immune biomarkers including calprotectin, human beta-defensin-2 (HBD-2), cathelicidin (LL-37), and secretory immunoglobulin A were also determined. This study was registered with the China Clinical Trial Center (ChiCTR2300074956).Results: Per-protocol analyses were conducted of 156 and 164 subjects in the IG and CG, respectively. The morbidity rate of eczema during the 6-month period was significantly lower in the IG versus CG (intention-to-treat analysis: 26.1% [47 of 180] vs. 66.7% [120 of 180], P&lt;0.01; per-protocol analysis: 30.1% [47 of 156] vs. 73.2% [120 of 164], P&lt;0.01). Probiotic supplementation was also associated with a lower risk of URTIs (IG vs. CG: 40.3% vs. 20.7%; risk ratio [RR], 0.752; 95% confidence interval [CI], 0.653\u20130.866) and acute tracheitis\/bronchitis (18.8% vs. 9.5%; RR, 0.897; 95% CI, 0.825\u20130.977). Bla80 intervention increased the relative abundance of Bifidobacterium bifidum, Bifidobacterium kashiwanohense PV20-2, Bifidobacterium longum, and Enterococcus dispar ATCC (American Type Culture Collection) 51266 while decreasing the abundance of Bacteroides thetaiotaomicron. Postintervention, the IG had significantly lower concentrations of LL-37 (3,509.31\u00b1587.89 pg\/g vs. 3,720.82\u00b1614.90 pg\/g, P=0.006) and HBD-2 (202.36\u00b156.35 pg\/g vs. 222.65\u00b156.23 pg\/g, P=0.005) than the CG. No serious adverse events were reported in either group.Conclusion: The daily administration of BLa80 at 5\u00d7109 CFU for 3 months in children aged 0\u20133 years reduced therisk of eczema, URTIs, and acute tracheitis\/bronchitis and beneficially altered the gut microbiome composition, fecal immune biomarkers, and functional gene composition without any adverse effects.<\/jats:p>","DOI":"10.3345\/cep.2025.01256","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:07:54Z","timestamp":1761808074000},"page":"150-162","update-policy":"https:\/\/doi.org\/10.3345\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bifidobacterium animalis subsp. lactis BLa80 for preventing allergic, respiratory, and gastrointestinal diseases in young children in China: a randomized double-blind placebo-controlled trial"],"prefix":"10.3345","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7455-0900","authenticated-orcid":true,"given":"Ke","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3190-7658","authenticated-orcid":true,"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8280-5600","authenticated-orcid":true,"given":"Kaihong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8714-6237","authenticated-orcid":true,"given":"Jiayi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5435-0530","authenticated-orcid":true,"given":"Shanshan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunrong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8308-9319","authenticated-orcid":true,"given":"Ziji","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0068-8664","authenticated-orcid":true,"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6526-5024","authenticated-orcid":true,"given":"Changqi","family":"Lium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1897","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-4642(21)00311-4"},{"key":"ref2","first-page":"1204","volume-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","year":"2020"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12819"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2023.10.001"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2020.29154.aie"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/nu12041039"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093094"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.66"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0439-x"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/nu15143123"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109164"},{"key":"ref12","first-page":"759","volume-title":"The therapeutic effect of probiotic bacteria on gastrointestinal diseases","author":"Sarowska","year":"2013"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd006895.pub4"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3920\/bm2020.0046"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3920\/bm2020.0233"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.635176"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2023.112052"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s42770-024-01276-3"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90772-a"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1479186"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/nu16223955"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2018.09.003"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00124"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i1.96199"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-024-01428-6"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-022-01411-z"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0089-z"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15618"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.02.011"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990572"},{"key":"ref31","first-page":"29","volume-title":"Functional gastrointestinal disorders: functional gastrointestinal disorders in children","author":"Waheed","year":"2018"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010184"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd006895.pub3"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.688137"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2340670"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034938"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.06.038"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209205"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/mpg.0000000000003675"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/apa.14270"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.14238\/pi28.3-4.1988.79-84"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-020-00410-6"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1712982"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2024.2626"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-023-02560-y"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/nu15153426"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.05.030"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2007.04.003"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2022.102178"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/nu12123673"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.771748"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2022.03.014"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15561"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2005.00370.x"},{"key":"ref55","first-page":"106S","volume-title":"Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial","author":"Holscher","year":"2012"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2021.1929344"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14880"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112991"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2023.171011"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00261.2020"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1097\/mco.0000000000000881"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.39.1135"},{"key":"ref63","first-page":"12","volume-title":"[Studies on serum lipid peroxides. 2. Observation on serum lipid peroxides and alpha-tocopherol in acute apoplexy]","author":"Liu","year":"1986"}],"updated-by":[{"DOI":"10.3345\/cep.2026.err01","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000}}],"container-title":["Clinical and Experimental Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-cep.org\/upload\/pdf\/cep-2025-01256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cep.org\/journal\/view.php?doi=10.3345\/cep.2025.01256","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cep.org\/upload\/pdf\/cep-2025-01256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T23:49:03Z","timestamp":1769989743000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-cep.org\/journal\/view.php?doi=10.3345\/cep.2025.01256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"URL":"https:\/\/doi.org\/10.3345\/cep.2025.01256","relation":{},"ISSN":["2713-4148"],"issn-type":[{"value":"2713-4148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]},"assertion":[{"value":"2025-06-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-30","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-15","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}